Policy | August 27, 2024
India's bioeconomy to reach US $300 billion by 2030: Dr. Jitendra Singh
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
Monkeypox infections are usually self-limiting lasting between 2-4 weeks and patients generally recover with supportive management
Application based on the Transcend FL trial in which Breyanzi showed deep and durable responses and a consistent and well-established safety profile
Capital expenditure expected to moderate to Rs. 5.6 billion in FY2025 from an estimated Rs. 7.6 billion in FY2024
Third approval in China for AstraZeneca and Daiichi Sankyo’s Enhertu in less than two years
Nearly 200 participants from 50 Unani Academia and Council participated
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
The acquisition of LumiraDx’s Point of Care technology received all required antitrust and regulatory clearances
Approval is based on data from two Phase III studies in branch and central retinal vein occlusion (RVO) showing early and sustained vision improvements non-inferior to aflibercept
Performed an autologous bone marrow transplant, using the patient’s own cells to reduce the chances of infection and rejection
Subscribe To Our Newsletter & Stay Updated
